Baker Bros. Advisors LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $7.9 Billion distributed in 87 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Incyte Corp with a value of $2.06B, Bei Gene, Ltd. with a value of $1.65B, Acadia Pharmaceuticals Inc with a value of $793M, Madrigal Pharmaceuticals, Inc. with a value of $526M, and Rhythm Pharmaceuticals, Inc. with a value of $277M.

Examining the 13F form we can see an decrease of $710M in the current position value, from $8.61B to 7.9B.

Baker Bros. Advisors LP is based out at New York, NY

Below you can find more details about Baker Bros. Advisors LP portfolio as well as his latest detailed transactions.

Portfolio value $7.9 Billion
Healthcare: $7.89 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History


  • Portfolio
  • No. of Stocks 87
  • Current Value $7.9 Billion
  • Prior Value $8.61 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 13 stocks
  • Additional Purchases 15 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.


Stay updated on Baker Bros. Advisors LP with notifications on news.